Gene transfer into the mammalian inner ear using HSV-1 and vaccinia virus vectors

被引:80
作者
Derby, ML
Sena-Esteves, M
Breakefield, XO
Corey, DP
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02114 USA
[4] Howard Hughes Med Inst, Boston, MA 02114 USA
关键词
gene transfer; gene therapy; viral vector; herpes simplex virus; vaccinia virus; cochlea; inner ear;
D O I
10.1016/S0378-5955(99)00045-3
中图分类号
R36 [病理学]; R76 [耳鼻咽喉科学];
学科分类号
100104 ; 100213 ;
摘要
The introduction of foreign genes into cells has become an effective means of achieving intracellular expression of foreign proteins, both for therapeutic purposes and for experimental manipulation. Gene delivery to the nervous system has been extensively studied, primarily using viral vectors. However, to date less work has focused on gene delivery to the inner ear, and existing studies have primarily used adenovirus and adeno-associated virus. Using two recombinant viral vectors, herpes simplex type 1 (HSV-1), and vaccinia virus, bearing the Escherichia coli lacZ gene, we tested gene delivery to the guinea pig cochlea in vivo with beta-galactosidase staining as an assay. The HSV-1 and vaccinia virus vectors were both found to infect and elicit transgene expression successfully in many cells in the guinea pig cochlea, including cells in the organ of Corti. These data demonstrate the feasibility of gene delivery to the inner ear using these two viral vectors. Such techniques may facilitate study of the auditory systems, and might be used to develop gene therapy strategies for some forms of hearing loss, (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 52 条
  • [1] BOVIATSIS EJ, 1994, CANCER RES, V54, P5745
  • [2] BOVIATSIS EJ, 1994, GENE THER, V1, P323
  • [3] BREAKEFIELD XO, 1997, CNS REGNERATION BASI, V4, P1281
  • [4] Brubaker JO, 1996, J IMMUNOL, V157, P1598
  • [5] DECREASED VIRULENCE OF RECOMBINANT VACCINIA VIRUS EXPRESSION VECTORS IS ASSOCIATED WITH A THYMIDINE KINASE-NEGATIVE PHENOTYPE
    BULLER, RML
    SMITH, GL
    CREMER, K
    NOTKINS, AL
    MOSS, B
    [J]. NATURE, 1985, 317 (6040) : 813 - 815
  • [6] Compact, synthetic, vaccinia virus early/late promoter for protein expression
    Chakrabarti, S
    Sisler, JR
    Moss, B
    [J]. BIOTECHNIQUES, 1997, 23 (06) : 1094 - 1097
  • [7] A PROSPECTIVE, RANDOMIZED STUDY OF COCHLEAR IMPLANTS
    COHEN, NL
    WALTZMAN, SB
    FISHER, SG
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (04) : 233 - 237
  • [8] EFFECTS OF CYCLOPHOSPHAMIDE ON THE PATHOGENESIS OF CYTOMEGALOVIRUS-INDUCED LABYRINTHITIS
    DARMSTADT, GL
    KEITHLEY, EM
    HARRIS, JP
    [J]. ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1990, 99 (12) : 960 - 968
  • [9] EFFECTS OF BACTERIAL-ENDOTOXIN APPLIED TO THE GUINEA-PIG COCHLEA
    DARROW, DH
    KEITHLEY, EM
    HARRIS, JP
    [J]. LARYNGOSCOPE, 1992, 102 (06) : 683 - 688
  • [10] Transfection of neonatal rat cochlear cells in vitro with an adenovirus vector
    Dazert, S
    Battaglia, A
    Ryan, AF
    [J]. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 1997, 15 (4-5) : 595 - 600